Align Technology | ALGN - Sales Revenues

Stock Price
157.25
Daily Change
-3.28 -2.04%
Monthly
-15.01%
Yearly
-16.49%
Q2 Forecast
165.29

Align Technology reported $1.04B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
3M USD 6B 100M Mar/2026
Align Technology USD 1.04B 10M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Cardinal Health USD 60.9B 4.73B Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Cooper Companies USD 1.02B 41.1M Dec/2025
CVS Health USD 100.4B 5.3B Mar/2026
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 880M 81M Mar/2026
Dexcom USD 1.19B 70M Mar/2026
Henry Schein USD 3.37B 30M Mar/2026
Idexx Laboratories USD 1.14B 50M Mar/2026
Insulet USD 761.7M 22.1M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Masimo USD 403.6M 8.9M Mar/2026
McKesson USD 92.3B 13.86B Mar/2026
Mettler Toledo International USD 947.13M 182.87M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Solventum Corp USD 2.01B 20M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Teleflex USD 548.3M 20.68M Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Veeva Systems USD 835.95M 24.72M Dec/2025
Waters USD 1.27B 338M Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026
Zoetis USD 2.3B 100M Mar/2026